Welcome to our dedicated page for Rubicon Organics news (Ticker: ROMJF), a resource for investors and traders seeking the latest updates and insights on Rubicon Organics stock.
Rubicon Organics Inc. (ROMJF) generates frequent news as a Canadian licensed producer focused on organic certified, premium and super-premium cannabis products. Company announcements often emphasize its position as the Canadian leader in certified organic and premium cannabis, its vertically integrated operations, and the performance of its brands Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.
News updates commonly include financial and operating results, where Rubicon Organics reports net revenue trends, Adjusted EBITDA, cash flow from operations, and market share in premium categories such as flower, pre-rolls, vapes, edibles, and topicals. These releases provide insight into how the company’s premium focus and cost discipline translate into operating performance over time.
Investors can also expect corporate and strategic announcements, such as the acquisition and licensing of the Cascadia facility in Hope, British Columbia, which the company states will expand production capacity by over 40%. Other news items cover credit agreements and financings, including capital loans and lines of credit secured against Cascadia, which Rubicon Organics plans to use for projects at its Pacifica and Cascadia facilities.
Additional coverage includes regulatory and licensing milestones, such as Health Canada licenses to cultivate, process, and store cannabis at Cascadia, as well as ESG reporting, executive appointments, and participation in investor conferences. Together, these updates give a detailed view of Rubicon Organics’ operations, capital structure, governance practices, and growth plans. For readers tracking ROMJF, the news feed offers a centralized way to follow developments in this premium-focused cannabis issuer.
Rubicon Organics (OTCQX: ROMJF) announced that its Cascadia facility in Hope, British Columbia, received a Health Canada licence to cultivate, process, and store cannabis.
The purpose-built, 47,500 sq ft indoor site adds 4,500 kg of annual production capacity, a 40% incremental increase that brings Rubicon's total premium annual capacity to 15,500 kg. Operations are underway and the company expects first revenue in H1 2026. Management said the facility uses advanced cultivation technologies and will support domestic demand and international market opportunities. Rubicon also renamed its Delta facility to Pacifica.
Rubicon Organics (OTCQX: ROMJF), Canada's leading premium licensed producer of organic certified cannabis products, has announced its participation in two upcoming investor events. The company will present at Small Cap Discoveries in Vancouver (September 29-30) and the Planet MicroCap Showcase in Toronto (October 21-23).
Additionally, Rubicon has engaged Atrium Research Corporation for research services at $3,500 monthly for 12 months starting October 1st, 2025, pending TSXV approval.
Rubicon Organics (OTCQX: ROMJF), Canada's leading premium organic cannabis producer, reported strong Q2 2025 financial results with net revenue of $15.0 million, up 24% year-over-year. The company achieved Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million.
Key developments include the acquisition of the Hope Facility, increasing production capacity by 40% to 15,500 kg annually, and completion of a $4.5 million private placement. The company expanded its product portfolio with the launch of 1964 Premium All-in-One Resin Vapes and maintained strong market share positions: 5.2% in premium flower/pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles.
For 2025, Rubicon expects growth in both revenue and Adjusted EBITDA, despite anticipated one-time costs of $1-2 million related to the Hope Facility start-up. The company is also exploring international market opportunities while maintaining focus on Canadian market leadership.
Rubicon Organics (OTCQX:ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q2 2025 financial results release for August 18, 2025, before market open.
The company will host a conference call to discuss the results on the same day at 7:00 AM PT / 10:00 AM ET. Investors can access the call through local dial-in, toll-free North American number, or via webcast through the company's earnings call registration.
Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.
The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.
Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.
Rubicon Organics (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced its upcoming Annual General and Special Meeting scheduled for July 31, 2025, at 10:00 AM PT. The meeting will be held at the Terminal City Club in Vancouver, with a live webcast option available.
The meeting agenda includes receiving 2024 financial statements, setting the board size at eight directors, electing directors, appointing PricewaterhouseCoopers LLP as auditors, and considering an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance. The record date for the meeting was set for June 25, 2025.
Rubicon Organics (OTCQX: ROMJF) has announced the launch of its new 1964 Supply Co.™ All-in-One (AIO) Full Spectrum Extract (FSE) Resin Vapes in the Canadian market. The product features the Comatose strain in a 0.5 gram format and will initially launch in British Columbia before expanding to other major Canadian provinces, excluding Quebec.
The launch follows the successful introduction of 510 FSE resin vape cartridges in May 2024. The company plans to launch two additional AIO offerings by the end of 2025. The product aims to attract legacy market consumers by offering high-quality FSE resin vapes at competitive price points, distinguishing itself in a market dominated by distillate-based products.
Rubicon Organics (ROMJF) has cleared all conditions precedent for acquiring the Hope Facility from Medipharm Labs Inc. The facility is a 47,500 square foot indoor cultivation facility located in Hope, British Columbia. This strategic acquisition is expected to significantly expand Rubicon's premium cannabis production capacity.
The company, which specializes in organic certified and premium cannabis products, anticipates closing the acquisition in the second quarter. CEO Margaret Brodie emphasized that this acquisition represents a pivotal step in meeting growing demand for their premium brands, accelerating innovation, and creating long-term shareholder value.